5th Apr 2006 07:00
Victrex PLC05 April 2006 Wednesday 5 April 2006 Victrex plc Interim Trading Update The Company announces its trading update for the six months ended 31 March 2006. First half sales volume amounted to approximately 1,110 tonnes, some 12 % aheadof the second half of last year (984 tonnes) and the previous first half of 988tonnes. •European sales saw renewed growth at 554 tonnes, 17 % up on the previous second half (472 tonnes) and 11% up on last year's first half (497 tonnes). •United States volume continued to grow with volume of 347 tonnes. This was 6% up on last year's strong second half of 327 tonnes and 23% ahead of the previous first half of 281 tonnes. •At 209 tonnes, Asia-Pacific sales have regained momentum, up 13% on the previous second half (185 tonnes) and in line with last year's record first half volume of 210 tonnes. •Invibio, the medical implant materials business, continued to show good revenue growth in the first half, although, as expected, not at the exceptionally high growth rates seen in 2005. The announcement of the Company's results for the six months ended 31 March 2006will be made on Tuesday, 6 June 2006. -Ends- For further information please contact: Victrex plc 020 7357 9477 (5 April 2006)Michael Peacock, Finance Director 01253 897700 (thereafter)Hogarth Partnership Limited 020 7357 9477Nick Denton / Barnaby Fry VICTREX PLC is an innovative, world leader in high performance materials throughthe manufacture of VICTREX(R) PEEK(TM) polymer, a high performance, easy toprocess, thermoplastic. VICTREX PEEK has a unique combination of chemical, wear, electrical, hydrolysisand temperature resistance, as well as excellent dimensional, mechanical andchemical stability combined with inherent purity and low flammability. End users specify VICTREX PEEK to reduce systems costs, improve partperformance, exploit greater design freedom and create a differentiatedapplication. VICTREX PEEK is used across a broad range of applications indiverse markets including transport, industrial, electronics and medical.Invibio(R), Victrex's biomaterial business, provides specialised solutions formedical device manufacturers. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Victrex